Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Immuno-oncology Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period.
This report presents the market size and development trends by detailing the Immuno-oncology Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Immuno-oncology Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Immuno-oncology Drugs industry and will help you to build a panoramic view of the industrial development.
Immuno-oncology Drugs Market, By Type:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Immuno-oncology Drugs Market, By Application:
Hospitals
Pharmacies
Online Pharmacies
Some of the leading players are as follows:
AbbVie, Inc.
Aduro BioTech.
Pfizer Inc.
Eli Lilly and Company
AstraZeneca, Plc
Sanofi S.A.
Merck & Co
Prometheus Therapeutics & Diagnostics
Celgene Corporation
Bavarian Nordic
Incyte
Gilead Sciences Inc
Amgen, Inc
Sanofi SA.
Novartis International AG
Bristol-Myers Squibb
Johnson & Johnson
Celldex Therapeutics
EMD Serono, Inc
Hoffmann-La Roche AG.
Galena Biopharma
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Immuno-oncology Drugs Market: Technology Type Analysis
-
4.1 Immuno-oncology Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Immuno-oncology Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Immune Checkpoint Inhibitors
4.3.2 Monoclonal Antibodies
4.3.3 Cytokine-Based Immunotherapy
4.3.4 Cancer Vaccines
4.3.5 CAR-T Cell Therapy
5 Immuno-oncology Drugs Market: Product Analysis
-
5.1 Immuno-oncology Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Immuno-oncology Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Immuno-oncology Drugs Market: Application Analysis
-
6.1 Immuno-oncology Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Immuno-oncology Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospitals
6.3.2 Pharmacies
6.3.3 Online Pharmacies
7 Immuno-oncology Drugs Market: Regional Analysis
-
7.1 Immuno-oncology Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Immuno-oncology Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 AbbVie, Inc.
9.1.1 AbbVie, Inc. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Aduro BioTech.
9.2.1 Aduro BioTech. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Pfizer Inc.
9.3.1 Pfizer Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Eli Lilly and Company
9.4.1 Eli Lilly and Company Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 AstraZeneca, Plc
9.5.1 AstraZeneca, Plc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Merck & Co
9.7.1 Merck & Co Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Prometheus Therapeutics & Diagnostics
9.8.1 Prometheus Therapeutics & Diagnostics Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Celgene Corporation
9.9.1 Celgene Corporation Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bavarian Nordic
9.10.1 Bavarian Nordic Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Incyte
9.11.1 Incyte Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Gilead Sciences Inc
9.12.1 Gilead Sciences Inc Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Amgen, Inc
9.13.1 Amgen, Inc Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Sanofi SA.
9.14.1 Sanofi SA. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Novartis International AG
9.15.1 Novartis International AG Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Bristol-Myers Squibb
9.16.1 Bristol-Myers Squibb Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Johnson & Johnson
9.17.1 Johnson & Johnson Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Celldex Therapeutics
9.18.1 Celldex Therapeutics Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 EMD Serono, Inc
9.19.1 EMD Serono, Inc Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Hoffmann-La Roche AG.
9.20.1 Hoffmann-La Roche AG. Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
9.21 Galena Biopharma
9.21.1 Galena Biopharma Company overview
9.21.2 Financial performance
9.21.3 Product benchmarking
9.21.4 Strategic initiatives
9.21.5 SWOT analysis
The List of Tables and Figures (Totals 89 Figures and 132 Tables)
Figure Immune Checkpoint Inhibitors Immuno-oncology Drugs market, 2015 - 2026 (USD Million)
Figure Monoclonal Antibodies Immuno-oncology Drugs market, 2015 - 2026 (USD Million)
Figure Cytokine-Based Immunotherapy Immuno-oncology Drugs market, 2015 - 2026 (USD Million)
Figure Cancer Vaccines Immuno-oncology Drugs market, 2015 - 2026 (USD Million)
Figure CAR-T Cell Therapy Immuno-oncology Drugs market, 2015 - 2026 (USD Million)
Figure Hospitals market, 2015 - 2026 (USD Million)
Figure Pharmacies market, 2015 - 2026 (USD Million)
Figure Online Pharmacies market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Immuno-oncology Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Immuno-oncology Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-oncology Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-oncology Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Immuno-oncology Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Immuno-oncology Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Immuno-oncology Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Immuno-oncology Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table AbbVie, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aduro BioTech. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca, Plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Prometheus Therapeutics & Diagnostics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celgene Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bavarian Nordic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Incyte Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Sciences Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi SA. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis International AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celldex Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table EMD Serono, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hoffmann-La Roche AG. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Galena Biopharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
